Arginine infusion in patients with septic shock increases nitric oxide production without haemodynamic instability

Clinical Science

Volumn 128, Issue 1, 2015, Pages 57-67

  Luiking, Yvette C ^a   Poeze, Martijn ^b,c   Deutz, Nicolaas E ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Catabolism; Haemodynamics; Metabolism; Protein; Sepsis; Stable isotope

Indexed keywords

ARGININE; CARBON DIOXIDE; LACTIC ACID; NITRIC OXIDE; CITRULLINE; UREA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; HEART STROKE VOLUME; HEMODYNAMIC MONITORING; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HUMAN; LUNG PRESSURE; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; SEPTIC SHOCK; SUPPLEMENTATION; AGED; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; DRUG EFFECTS; ENZYMOLOGY; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; SHOCK, SEPTIC;

AGED; ARGININE; BLOOD PRESSURE; CASE-CONTROL STUDIES; CITRULLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMODYNAMICS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NITRIC OXIDE; SHOCK, SEPTIC; UREA;

EID: 84907222946     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20140343     Document Type: Article

References (50)

1. Martin, G. S., Mannino, D. M., Eaton, S. and Moss, M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554
2. Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J. L. and Ramsay, G. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 31, 1250-1256
3. Luiking, Y. C., Poeze, M., Ramsay, G. and Deutz, N. E. (2009) Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production. Am. J. Clin. Nutr. 89, 142-152
4. Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R. et al. (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit. Care Med. 41, 580-637
5. Poeze, M., Solberg, B. C., Greve, J. W. and Ramsay, G. (2005) Monitoring global volume-related hemodynamic or regional variables after initial resuscitation: what is a better predictor of outcome in critically ill septic patients? Crit. Care Med. 33, 2494-2500
6. De Backer, D., Creteur, J., Preiser, J. C., Dubois, M. J. and Vincent, J. L. (2002) Microvascular blood flow is altered in patients with sepsis. Am. J. Respir. Crit. Care Med. 166, 98-104
7. Sakr, Y., Dubois, M. J., De Backer, D., Creteur, J. and Vincent, J. L. (2004) Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit. Care Med. 32, 1825-1831
8. Neviere, R., Mathieu, D., Chagnon, J. L., Lebleu, N., Millien, J. P. and Wattel, F. (1996) Skeletal muscle microvascular blood flow and oxygen transport in patients with severe sepsis. Am. J. Respir. Crit. Care Med. 153, 191-195
9. Lehr, H. A., Bittinger, F. and Kirkpatrick, C. J. (2000) Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy? J. Pathol. 190, 373-386
10. Derikx, J. P., Poeze, M., van Bijnen, A. A., Buurman, W. A. and Heineman, E. (2007) Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis. Shock 28, 544-548
11. Engelberger, R. P., Pittet, Y. K., Henry, H., Delodder, F., Hayoz, D., Chiolero, R. L., Waeber, B., Liaudet, L., Berger, M. M. and Feihl, F. (2011) Acute endotoxemia inhibits microvascular nitric oxide-dependent vasodilation in humans. Shock 35, 28-34
12. Villalpando, S., Gopal, J., Balasubramanyam, A., Bandi, V. P., Guntupalli, K. and Jahoor, F. (2006) In vivo arginine production and intravascular nitric oxide synthesis in hypotensive sepsis. Am. J. Clin. Nutr. 84, 197-203
13. Luiking, Y. C., Poeze, M., Dejong, C. H., Ramsay, G. and Deutz, N. E. (2004) Sepsis: an arginine deficiency state? Crit. Care Med. 32, 2135-2145
14. Luiking, Y. C., Ten Have, G. A., Wolfe, R. R. and Deutz, N. E. (2012) Arginine de novo and nitric oxide production in disease states. Am. J. Physiol. Endocrinol. Metab. 303, E1177-E1189
15. Davis, J. S. and Anstey, N. M. (2011) Is plasma arginine concentration decreased in patients with sepsis? A systematic review and meta-analysis. Crit. Care Med. 39, 380-385
16. Druml, W., Heinzel, G. and Kleinberger, G. (2001) Amino acid kinetics in patients with sepsis. Am. J. Clin. Nutr. 73, 908-913
17. Hallemeesch, M. M., Lamers, W. H. and Deutz, N. E. (2002) Reduced arginine availability and nitric oxide production. Clin. Nutr. 21, 273-279
18. Nijveldt, R. J., Teerlink, T., Van Der Hoven, B., Siroen, M. P., Kuik, D. J., Rauwerda, J. A. and van Leeuwen, P. A. (2003) Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin. Nutr. 22, 23-30
19. Nakajima, Y., Baudry, N., Duranteau, J. and Vicaut, E. (2006) Effects of vasopressin, norepinephrine, and L-arginine on intestinal microcirculation in endotoxemia. Crit. Care Med. 34, 1752-1757
20. Poeze, M., Bruins, M. J., Kessels, F., Luiking, Y. C., Lamers, W. H. and Deutz, N. E. (2011) Effects of L-arginine pretreatment on nitric oxide metabolism and hepatosplanchnic perfusion during porcine endotoxemia. Am. J. Clin. Nutr. 93, 1237-1247
21. Bruins, M. J., Soeters, P. B., Lamers, W. H., Meijer, A. J. and Deutz, N. E. P. (2002) L-arginine supplementation in hyperdynamic endotoxemic pigs: effect on nitric oxide synthesis by the different organs. Crit. Care Med. 30, 508-517
22. Bruins, M. J., Soeters, P. B., Lamers, W. H. and Deutz, N. E. (2002) L-arginine supplementation in pigs decreases liver protein turnover and increases hindquarter protein turnover both during and after endotoxemia. Am. J. Clin. Nutr. 75, 1031-1044
23. Spronk, P. E., Ince, C., Gardien, M. J., Mathura, K. R., Oudemans-van Straaten, H. M. and Zandstra, D. F. (2002) Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 360, 1395-1396
24. Kalil, A. C., Sevransky, J. E., Myers, D. E., Esposito, C., Vandivier, R. W., Eichacker, P., Susla, G. M., Solomon, S. B., Csako, G., Costello, R. et al. (2006) Preclinical trial of L-arginine monotherapy alone or with N-acetylcysteine in septic shock. Crit. Care Med. 34, 2719-2728
25. Heyland, D. K., Novak, F., Drover, J. W., Jain, M., Su, X. and Suchner, U. (2001) Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 286, 944-953
26. Kalil, A. C. and Danner, R. L. (2006) L-arginine supplementation in sepsis: beneficial or harmful? Curr. Opin. Crit. Care 12, 303-308
27. Barbul, A. and Uliyargoli, A. (2007) Use of exogenous arginine in multiple organ dysfunction syndrome and sepsis. Crit. Care Med. 35, S564-S567
28. Luiking, Y. C. and Deutz, N. E. (2007) Exogenous arginine in sepsis. Crit. Care Med. 35, S557-S563
29. Montejo, J. C., Zarazaga, A., Lopez-Martinez, J., Urrutia, G., Roque, M., Blesa, A. L., Celaya, S., Conejero, R., Galban, C., Garcia de Lorenzo, A. et al. (2003) Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clin. Nutr. 22, 221-233
30. Zhou, M. and Martindale, R. G. (2007) Arginine in the critical care setting. J. Nutr. 137, 1687S-1692S
31. Engelen, M. P., Com, G., Luiking, Y. C. and Deutz, N. E. (2013) Stimulated nitric oxide production and arginine deficiency in children with cystic fibrosis with nutritional failure. J. Pediatr. 163, 369-375
32. Boger, R. H. and Bode-Boger, S. M. (2001) The clinical pharmacology of L-arginine. Annu. Rev. Pharmacol. Toxicol. 41, 79-99
33. Abumrad, N. N., Rabin, D., Diamond, M. P. and Lacy, W. W. (1981) Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism 30, 936-940
34. van Eijk, H. M., Rooyakkers, D. R. and Deutz, N. E. (1993) Rapid routine determination of amino acids in plasma by highperformance liquid chromatography with a 2-3 microns Spherisorb ODS II column. J. Chromatogr. 620, 143-148
35. van Eijk, H. M., Suylen, D. P., Dejong, C. H., Luiking, Y. C. and Deutz, N. E. (2007) Measurement of amino acid isotope enrichment by liquid chromatography mass spectroscopy after derivatization with 9-fluorenylmethylchloroformate. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 856, 48-56
36. Bode-Boger, S. M., Boger, R. H., Galland, A., Tsikas, D. and Frolich, J. C. (1998) L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. Br. J. Clin. Pharmacol. 46, 489-497
37. Morris, C. R., Poljakovic, M., Lavrisha, L., Machado, L., Kuypers, F. A. and Morris, Jr, S. M. (2004) Decreased arginine bioavailability and increased serum arginase activity in asthma. Am. J. Respir. Crit. Care Med. 170, 148-153
38. Kao, C. C., Bandi, V., Guntupalli, K. K., Wu, M., Castillo, L. and Jahoor, F. (2009) Arginine, citrulline and nitric oxide metabolism in sepsis. Clin. Sci. 117, 23-30
39. Ochoa, J. B., Udekwu, A. O., Billiar, T. R., Curran, R. D., Cerra, F. B., Simmons, R. L. and Peitzman, A. B. (1991) Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 214, 621-626
40. Kelm, M. (1999) Nitric oxide metabolism and breakdown. Biochim. Biophys. Acta 1411, 273-289
41. Hallemeesch, M. M., Janssen, B. J. A., De Jonge, W. J., Soeters, P. B., Lamers, W. H. and Deutz, N. E. P. (2003) NO production by cNOS and iNOS reflects blood pressure changes in LPS-challenged mice. Am. J. Physiol. Endocrinol. Metab. 285, E871-E875
42. Titheradge, M. A. (1999) Nitric oxide in septic shock. Biochim. Biophys. Acta 1411, 437-455
43. Scott, J. A., Mehta, S., Duggan, M., Bihari, A. and McCormack, D. G. (2002) Functional inhibition of constitutive nitric oxide synthase in a rat model of sepsis. Am. J. Respir. Crit. Care Med. 165, 1426-1432
44. Helmer, K. S., West, S. D., Shipley, G. L., Chang, L., Cui, Y., Mailman, D. and Mercer, D. W. (2002) Gastric nitric oxide synthase expression during endotoxemia: implications in mucosal defense in rats. Gastroenterology 123, 173-186
45. Klaude, M., Mori, M., Tjader, I., Gustafsson, T., Wernerman, J. and Rooyackers, O. (2012) Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. Clin. Sci. 122, 133-142
46. Lorente, J. A., Landin, L., De Pablo, R., Renes, E. and Liste, D. (1993) L-arginine pathway in the sepsis syndrome. Crit. Care Med. 21, 1287-1295
47. Massara, F., Martelli, S., Ghigo, E., Camanni, F. and Molinatti, G. M. (1979) Arginine-induced hypophosphatemia and hyperkaliemia in man. Diabete Metab. 5, 297-300
48. Floyd, Jr, J. C., Fajans, S. S., Conn, J. W., Knopf, R. F. and Rull, J. (1966) Stimulation of insulin secretion by amino acids. J. Clin. Invest. 45, 1487-1502
49. Flam, B. R., Eichler, D. C. and Solomonson, L. P. (2007) Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric Oxide, 17, 115-121
50. Wijnands, K. A., Vink, H., Briede, J. J., van Faassen, E. E., Lamers, W. H., Buurman, W. A. and Poeze, M. (2012) Citrulline a more suitable substrate than arginine to restore NO production and the microcirculation during endotoxemia. PLoS One, 7, e37439